Inhibition of nitric oxide production reverses diabetes-induced Kupffer cell activation and Klebsiella pneumonia liver translocation.

PubWeight™: 0.76‹?›

🔗 View Article (PMID 28493939)

Published in PLoS One on May 11, 2017

Authors

Shu-Han Lin1,2, Pei-Hsuan Chung3, Ying-Ying Wu4, Chang-Phone Fung1,5, Ching-Mei Hsu3, Lee-Wei Chen6,7

Author Affiliations

1: Institute of Emergency and Critical Care Medicine, National Yang-Ming University, Taipei, Taiwan.
2: Department of Nursing, National Taiwan University Hospital, Taipei, Taiwan.
3: Department of Biological Sciences, National Sun Yat-Sen University, Kaohsiung, Taiwan.
4: Department of Surgery, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
5: Division of Infectious Diseases, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
6: Department of Surgery, Kaohsiung Veterans General Hospital, 386, Ta-Chung 1st Road, Kaohsiung, Taiwan. chenlw2001@yahoo.com.tw.
7: Institute of Emergency and Critical Care Medicine, National Yang-Ming University, Taipei, Taiwan. chenlw2001@yahoo.com.tw.

Articles cited by this

Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature (2012) 10.74

Primary liver abscess due to Klebsiella pneumoniae in Taiwan. Clin Infect Dis (1998) 7.51

Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice. Gastroenterology (2010) 3.52

The Ins2Akita mouse as a model of early retinal complications in diabetes. Invest Ophthalmol Vis Sci (2005) 2.83

Role of oxygen-derived free radicals in digestive tract diseases. Surgery (1983) 2.32

Humane endpoints in shock research. Shock (2004) 2.18

Gene expressions of Toll-like receptor 2, but not Toll-like receptor 4, is induced by LPS and inflammatory cytokines in mouse macrophages. J Immunol (2000) 1.86

Dosage-related bifidogenic effects of galacto- and fructooligosaccharides in formula-fed term infants. J Pediatr Gastroenterol Nutr (2002) 1.80

Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut. J Physiol (2011) 1.79

Secreted enteric antimicrobial activity localises to the mucus surface layer. Gut (2008) 1.75

Intestinal dysbiosis: a possible mechanism of alcohol-induced endotoxemia and alcoholic steatohepatitis in rats. Alcohol Clin Exp Res (2009) 1.75

Innate immune response and hepatic inflammation. Semin Liver Dis (2007) 1.70

Inhibition of inducible nitric oxide synthase ameliorates endotoxin-induced gut mucosal barrier dysfunction in rats. Gastroenterology (1997) 1.67

Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia. Hepatology (1993) 1.61

Hepatic inflammation in rats with experimental small intestinal bacterial overgrowth. Gastroenterology (1990) 1.59

Pattern recognition receptors: a contemporary view on liver diseases. Hepatology (2006) 1.47

A critical role for nitric oxide in intestinal barrier function and dysfunction. Am J Physiol (1996) 1.33

Characterization of bacteria in biopsies of colon and stools by high throughput sequencing of the V2 region of bacterial 16S rRNA gene in human. PLoS One (2011) 1.25

Assessment of hypermucoviscosity as a virulence factor for experimental Klebsiella pneumoniae infections: comparative virulence analysis with hypermucoviscosity-negative strain. BMC Microbiol (2011) 1.24

Small intestinal bacterial overgrowth in human cirrhosis is associated with systemic endotoxemia. Am J Gastroenterol (2002) 1.22

Nitric oxide-mediated intestinal injury is required for alcohol-induced gut leakiness and liver damage. Alcohol Clin Exp Res (2009) 1.15

Toll-like receptor 4-dependent Kupffer cell activation and liver injury in a novel mouse model of parenteral nutrition and intestinal injury. Hepatology (2012) 1.13

Gut microbiota and probiotics in chronic liver diseases. Dig Liver Dis (2010) 1.05

Association between small intestinal bacterial overgrowth and peripheral bacterial DNA in cirrhotic patients. Dig Dis Sci (2009) 1.01

Intestinal and immunological effects of daily oral administration of Lactobacillus salivarius CECT5713 to healthy adults. Anaerobe (2010) 0.97

Immune response and pathophysiological features of Klebsiella pneumoniae liver abscesses in an animal model. Lab Invest (2011) 0.96

Bacterial translocation and changes in the intestinal microbiome associated with alcoholic liver disease. World J Hepatol (2012) 0.95

Severe bacteremia results in a loss of hepatic bacterial clearance. Am J Respir Crit Care Med (2006) 0.89

Insulin-like growth factor-1 levels contribute to the development of bacterial translocation in sepsis. Am J Respir Crit Care Med (2010) 0.88

Receptor activator of nuclear factor-κB ligand (RANKL) protects against hepatic ischemia/reperfusion injury in mice. Hepatology (2012) 0.88

Lactobacillus salivarius reverse diabetes-induced intestinal defense impairment in mice through non-defensin protein. J Nutr Biochem (2016) 0.75